Join us for a seminar to learn how Illumina technology can help you
uncover the answers to drive your research forward.

During this event, Illumina experts will present an overview of
next-generation sequencing (NGS), including recent application and
platform updates, discussing the basic concepts and key advantages
over traditional technologies.

Explore our smallest and most cost-effective sequencer ever. Join
Bellal Moghis and Gary Schroth as they introduce our newest
system—iSeq 100. They’ll walk through installation and also review
applications and methods. Find out how you can make the most of your
new lab partner.

With the dramatically increasing amount of sequence data generation
and the significant reduction of sequencing costs, rapid, easy, and
accurate data analytics becomes the critical bottleneck in adopting
next-generation sequencing (NGS) in the public health sector. To this
end, CosmosID has developed a cloud-based microbial genomics platform
featuring with world’s largest curated genome databases and scaling
computational power to keep pace with the ever-increasing amount of
data generation. The platform brings together the most comprehensive
and ultrafast “sequence to answer” workflow for easy, accurate, and
highly resolved profiling of cross-disciplinary microbiome data. In
this webinar, various aspects of the platform will be presented with
reference to recent studies on water and wastewater treatment, food
safety, molecular epidemiology, and multi-kingdom microbiome profiling
and characterization. Key technologies that will be showcased include
strain-level metagenomics, metatranscriptomics, metagenomic assembly,
and molecular sub-typing.

See what happens when a leading library prep is optimized to run on
next-generation sequencing (NGS) systems from Illumina. Join Mitu
Chaudhary and Claire White as they present data to demonstrate the
robust performance of AmpliSeq for Illumina from a wide variety of
sample types.

The latest sequencing technologies enable unprecedented throughput
and redefine limits for many labs. To adapt, these labs must redefine
how they work – by automating tasks to reduce touchpoints and by
simplifying workflows with integration and robust analysis tools. In
this webinar, we describe BaseSpace™ Sequence Hub and how the newest
features support high throughput, high-volume sequencing. We
demonstrate how customers can progress from flowcell loading to
variant analysis with zero touchpoints by using the Whole Genome
Sequencing or Edico Genome DRAGEN apps. Additionally, we describe how
the integration with BaseSpace™ Variant Interpreter enables users to
interpret and generate reports of identified variants.

Add this event to your calendar12/07/17 10 AM (PT)12/07/17Enabling efficient Discovery and Clinical Research in drug response: Application of a targeted Next-Generation Sequencing Assay for Pharmacogenetics

Pharmacogenetic (PGx) testing enables researchers to understand a
person’s genetic propensity for a therapeutic response or an adverse
reaction to particular medications. Recently the NIH’s Precision
Medicine Initiative has begun a nationwide effort to individualize a
subject’s treatment program, while the FDA has already included PGx
information in over one hundred drug labels. Serious drug reaction
events are likely to become more prevalent as more drugs become
available and the number of pharmaceuticals each person is taking
increases. To understand the occurrence of these events, sequencing
genomic regions associated with metabolism of a wide-spectrum of drug
classes can help inform clinical researchers, and better characterize
the frequency of known and novel haplotypes within validated genes
involved in drug metabolism pathways.

In this
presentation, we will describe a method and workflow for targeted
pharmacogenetic gene sequencing using Kailos’ TargetRichTM PGxComplete assay.

The Webinar Series will feature HLA laboratory directors presenting
case studies from samples prepared with TruSight™ HLA, sequenced with
Illumina next-generation sequencing (NGS) MiSeq or MiniSeq systems,
and analyzed using TruSight HLA Assign software. Presentations will be
followed by an interactive question and answer session.

Webinar Archive Sign Up Form

Your email address is never shared with third parties.

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

For Research Use Only. Not for use in diagnostic procedures (except as specifically noted).